This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Dr Fiona Marshall

Dr Fiona Marshall

Name:

Dr Fiona Marshall FAcadMedSci FSB HonFBPhS

Organisation:

MSD

Year elected:

2018

Primary professional setting:

Industry

Fiona Marshall is the Chief Scientific officer and a founder of Heptares Therapeutics – a drug discovery and development biotechnology company. She is also Executive VP and CSO of Sosei Group which acquired Heptares in 2015. Fiona has a BSc in biochemistry from Bath University and a PhD in neuroscience from Cambridge University. She has more than 25 years' experience in drug discovery including senior positions at GSK and Millennium. Fiona is recognised for her expertise in the field of G-protein coupled receptors (GPCRs) and has published extensively in this area. Fiona is on the Board of Trustees of Alzheimer’s Research UK, the council of the Academy of Medical sciences and on advisory boards of the Crick Institute and the Wellcome Trust. She is chair of the MRC DPFS committee. She won the 2012 WISE Women of Outstanding Achievement for Innovation and Entrepreneurship and the 2015 RSC Malcolm Campbell Award for chemistry.